A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

Christine Léauté-Labrèze, Peter H. Hoeger, J. Mazereeuw‐Hautier, +45

New England Journal of Medicine

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study

Marie Kostine, L. Rouxel, Thomas Barnetche, +17

Annals of the Rheumatic Diseases

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

Alexander Stratigos, Aleksandar Sekulić, Ketty Peris, +35

The Lancet Oncology

MedicineHedgehog Inhibitor TherapyDermatologyCancer TreatmentOncology +3

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?

Stéphane Dalle, M. Beylot‐Barry, Martine Bagot, +13

British Journal of Dermatology

Vitiligo-like lesions occurring in patients receiving anti-programmed cell death–1 therapies are clinically and biologically distinct from vitiligo

M. Larsabal, A. Marti, C. Jacquemin, +7

Journal of the American Academy of Dermatology

Vitiligo-like LesionsAutoimmune DiseaseImmunologyCell DeathPathology +4

Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities

C. Léauté‐Labrèze, S. Prey, Khaled Ezzedine

Journal of the European Academy of Dermatology and Venereology

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial

S. Prey, Khaled Ezzedine, A. Doussau, +18

British Journal of Dermatology

Infantile haemangioma: Part II. Risks, complications and treatment

C. Léauté‐Labrèze, S. Prey, Khaled Ezzedine

Journal of the European Academy of Dermatology and Venereology

Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events

Marie Kostine, Eleonora Mauric, Alice Tison, +18

European Journal of Cancer

Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey

C. Lesage, Christine Longvert, S. Prey, +13

Journal of Immunotherapy

ImmunodeficienciesImmunologyImmune RegulationPathologyAnti-tnfα Treatment +21